Christopher Brusalis, MD
Sports Medicine · Uniondale, NYNPI 1033641394
Payments from drug & device makers
What this record shows
This record is dominated by education: $23,207 of the $36,632 with a category attached, or 63.4%. Smith+Nephew accounts for 64.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $20,948 and has fallen 94.1% since, to $1,231 in 2025.
Across 109 payments — averaging $336.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$23K
- Stryker$5K
- Medical Device Business Services, Inc.$2K
- Exactech, Inc.$2K
- Depuy Synthes Products, Inc.$2K
- Arthrex$2K
- plus $1K from 6 others
What the payments were for
- Consulting fees$1,3954%
- Travel & lodging$7,10719%
- Food & beverage$4,92313%
- Education$23,20763%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 8 | $23,440 |
| Stryker | 33 | $4,845 |
| Medical Device Business Services, Inc. | 19 | $2,134 |
| Exactech, Inc. | 9 | $1,769 |
| Depuy Synthes Products, Inc. | 3 | $1,729 |
| Arthrex | 25 | $1,606 |
| Johnson & Johnson | 5 | $404 |
| Suvon Surgical LLC | 2 | $213 |
| Osteoremedies, LLC | 1 | $194 |
| Linkbio Corp | 2 | $172 |
| Vericel Corporation | 1 | $105 |
| Medwest Associates | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EQUINOXE$1,552
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$1,510
- DYNACORD$1,325
- SALVATION$1,043
- ICONIX$505
- NANOPASS$428
- AEQUALIS PERFORM$387
- Velys$334
- NANOTACK FLEX$324
- HEALIX KNOTLESS PEEK$321
- INHANCE$252
- EXACTECHGPS$234
- BIOWASH Surgical Irrigation$194
- OsteoBoost Select 5cc$194
- Remedy Spacer$194
- Remedy Spectrum GV Spacer$194
- BioBrush$194
- HIPCHECK$165
- FORMULA$159
- AIR$159
How this compares
$36,632 in reported general payments places this provider in the 85th percentile of 403 sports medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 86 | $425 |
| Meloxicam | 113 | $397 |
| Pantoprazole Sodium | 62 | $396 |
| Ondansetron OdtOndansetron | 58 | $205 |
| Gabapentin | 63 | $146 |
| Methylprednisolone | 14 | $121 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Uniondale
- Steven LeeNyc$3.3M
- James PaciWoodbury$2.1M
- Gregory DifeliceNew York$1.8M
- Ilya VoloshinRochester$786K
- Theodore BlaineNew York$765K
- Robert MeislinNew York$720K
- Danyal NawabiNew York$592K
- Stephen NicholasNyc$586K
- Riley WilliamsNew York$512K
- Bryan KellyNew York$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.